Pathstone Family Office’s Frontline FRO Stock Holding History

Pathstone Family Office’s Portfolio FRO Stock Details FRO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	$254K	Buy	13,523 +3,252	+32%	+$54.7K	﹤0.01%	1386
2023 Q2	$149K	Buy	+10,271	New	+$153K	﹤0.01%	1172
2021 Q1	–	Sell	-3,908	Closed	-$24K	–	912
2020 Q4	$24K	Buy	+3,908	New	+$25.1K	﹤0.01%	647

Other funds holding FRO

Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Voloridge Investment Management Jupiter, Florida $25B AUM 28.08% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Pathstone Family Office's FRO Position: Q3 2023 in Review

Pathstone Family Office increased its Frontline (FRO) stake by 32% in Q3 2023, buying an estimated $54.7K and bringing the position to 13,523 shares worth $254K. The position accounts for ﹤0.01% of the portfolio, ranked #1386.

Pathstone Family Office first reported a position in FRO in Q4 2020 and has held it in 3 quarters since. 167 funds tracked by Wall St. Rank hold FRO as of Q3 2023.

Pathstone Family Office held 13,523 shares of Frontline worth $254K as of Q3 2023.
Pathstone Family Office bought 3,252 Frontline shares in Q3 2023, an estimated $54.7K.
Frontline made up ﹤0.01% of Pathstone Family Office's portfolio in Q3 2023, its #1386 holding.
Pathstone Family Office first reported a position in Frontline in Q4 2020 and has held it in 3 quarters since.
167 funds tracked by Wall St. Rank held Frontline as of Q3 2023.

Based on Pathstone Family Office's 13F filing for Q3 2023, filed 8 Nov 2023.